NorthWest Biotherapeutics Inc (NWBO)

[hankmanhub]

I am not saying this will happen. I am just giving you the possible theory by which it could happen. I personally think they will use this PIII trial to enable several much smaller and shorter trials in several selected solid cancers, selected with the input of the RAs to obtain approvals for all solid cancers in a very accelerated manner.

Once this is approved for GBM, and it is seen as very effective and viewed as a platform for all solid cancers, their will be much demand for off label use and great demand for compassionate use. This will build immense pressure on the RAs from thousands of cancer patients to get this approved for their solid cancers as well and quickly given the great safety record of the treatment. Cancer patients do not have the luxury of time!